NCT06649422 2024-10-18
Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study
Shandong University
Not yet recruiting
Clinical Trials
4 trialsNCT06075212 2023-10-10
Immune Reconstitution After Allo-HSCT and Blinatumomab
Sichuan University
Unknown
NCT05837689 2023-05-01
Minimal Residual Disease Quantification by Next-generation Sequencing in Pediatric B-ALL Children Patients Treated With Blinatumomab Consolidation
The Children's Hospital of Zhejiang University School of Medicine
Unknown
NCT03318770 2022-10-12
Post-Frontline Sequential Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto
Unknown